ArticleAmerican journal of hematology2024

Safety and long-term survival results of the addition of inotuzumab ozogamicin to the conditioning regimen of allogeneic stem cell transplantation: A single-center phase 1,2 trial.

Issa F Khouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.